Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.

EBioMedicine·2026
Same author

Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case-control studies in England, Wales, Scotland, and Northern Ireland.

The Lancet regional health. Europe·2026
Same author

Acute COVID-19 mortality in England in the omicron era: a national-level matched cohort study.

Epidemiology and infection·2026
Same author

Delayed Exposures and Pre-Exposure Periods in Self-Controlled Case Series Studies.

Statistics in medicine·2026
Same author

Preclinical validation of AAV9-TECPR2 gene therapy in a novel knock-in model of TECPR2-related disorder.

bioRxiv : the preprint server for biology·2026
Same author

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.

The Lancet. Microbe·2026
Same journal

Suggestive associations between genetically predicted gut microbiota and endometriosis: a two-sample Mendelian randomization study.

Journal of medical microbiology·2026
Same journal

Whole-genome sequencing of <i>Listeria monocytogenes</i> from maternal and neonatal clinical isolates in Kuwait.

Journal of medical microbiology·2026
Same journal

The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis.

Journal of medical microbiology·2026
Same journal

R pyocin sensitivity of <i>Pseudomonas aeruginosa</i> clinical isolates from different disease types.

Journal of medical microbiology·2026
Same journal

Investigation of the efficacy of high-dose flucloxacillin therapy for borderline oxacillin-resistant (BORSA) <i>Staphylococcus aureus</i> infections of <i>Galleria mellonella</i> larvae.

Journal of medical microbiology·2026
Same journal

Corrigendum: Cases of high consequence infectious diseases identified in the UK, 1962-2023.

Journal of medical microbiology·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Regression models for censored serological data.

George Kafatos1,2, Nick Andrews2, Kevin J McConway1

  • 1Department of Mathematics and Statistics, The Open University, Milton Keynes MK7 6AA, UK.

Journal of Medical Microbiology
|September 25, 2012
PubMed
Summary
This summary is machine-generated.

Censored regression methods improve standardization of serosurvey results by providing more accurate estimates when dealing with censored serological data. Interval-censored regression is particularly effective for dilution series assay data.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on: November 21, 2023

Related Experiment Videos

Last Updated: May 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on: November 21, 2023

Area of Science:

  • Epidemiology
  • Biostatistics
  • Immunology

Background:

  • Standardizing serosurvey results across different laboratories and assays is crucial for accurate epidemiological analysis.
  • Censored serological measurements, common in serosurveys, can introduce bias into regression analyses.
  • The European Sero-Epidemiology Network 2 project highlighted the need for robust methods to handle such data.

Purpose of the Study:

  • To assess the impact of censored serological measurements on regression equations used for standardizing serosurvey results.
  • To compare the performance of various statistical methods for adjusting censored data.
  • To identify the most accurate method for standardizing serological measurements from different laboratories.

Main Methods:

  • Comparison of statistical methods including deletion, simple substitution, multiple imputation, and censored regression.
  • Simulations generated from scenarios based on serological panel comparisons from multiple national laboratories and assays.
  • Evaluation of methods under varying proportions of censored data and different regression assumptions.

Main Results:

  • Simple substitution and deletion methods performed adequately with low censoring (<20%).
  • Censored regression generally yielded estimates closer to the true values across various scenarios.
  • Interval-censored regression provided the least biased estimates specifically for assay data from dilution series.

Conclusions:

  • Censored regression methods offer superior accuracy for standardizing serosurvey data compared to simpler methods.
  • Interval-censored regression is recommended for assay data derived from dilution series due to its minimal bias.
  • Accurate standardization of serological data is essential for reliable epidemiological surveillance.